Bayer Cements Supplement Sales Gains From Initial COVID Boost

A year on from the start of the COVID-19 outbreak and a global rush for supplements, Bayer has cemented these sales gains with slight growth at its Nutritionals business in Q1.

Bayer cross
• Source: Shutterstock

COVID-19 sent its dietary supplement sales soaring but a year on Bayer has been able to solidify those initial gains by its Nutritionals franchise.

While Nutritionals turnover only edged up by 0.6% - 4.7% adjusted for currency and portfolio effects – to €353m ($426m)...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography